Atlas Trials

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

Clinical trial NCT06797518 · RECRUITING

Trial details

NCT number
NCT06797518
Sponsor
Novartis Pharmaceuticals
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Glomerulonephritis, IGAImmunoglobulin A Nephropathy
Start date
2025-02-21
Primary completion
2027-11-27
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.